Table 1 Summary data for retinitis pigmentosa patients and the retinal progenitor cells
From: Long-term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients
| Â | Â | Â | BCVA (logMAR) | Donor cells | ||
|---|---|---|---|---|---|---|
Patients | Age (years) | Sex | OS | OD | Gestational age (weeks) | Viability |
1 | 42 | M | 1.56 | 1.6 | 14 | >98% |
2 | 33 | F | 1.30 | 1.3 | 15 | >98% |
3 | 34 | M | 1.00 | 0.8 | 12 | 90–93% |
4 | 19 | M | 0.35 | 0.3 | 12 | 95% |
5 | 46 | F | 1.52 | 0.9 | 15 | 96% |
6 | 19 | F | 1.30 | 0.4 | 12 | 94% |
7 | 53 | F | 2.00 | 1.8 | 12 | 95% |
8 | 38 | F | 0.92 | 1.0 | 12 | 93% |